CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.